Please use this identifier to cite or link to this item: https://hdl.handle.net/1959.11/2720
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSchmidt, Mathiasen
dc.contributor.authorMorgan, Michelleen
dc.contributor.authorBone, Kerryen
dc.contributor.authorMcMillan, Janiceen
local.source.editorEditor(s): Simon Mills and Kerry Boneen
dc.date.accessioned2009-10-27T16:05:00Z
dc.date.issued2005en
dc.identifier.citationThe Essential Guide to Herbal Safety, p. 155-221en
dc.identifier.isbn0443071713en
dc.identifier.isbn9780443071713en
dc.identifier.other615.321/E78en
dc.identifier.urihttps://hdl.handle.net/1959.11/2720en
dc.description.abstractIn November 2001 the German Health Authority (BfArM; see Appendix 1 for abbreviations used) announced that it was intending to ban the use of kava ('Piper methysticum') because of reported cases linking kava consumption with hepatotoxicity. Despite submissions from manufacturers, therapeutic use of kava was banned altogether in Germany in 2002 and several other countries such as Japan, France, and Canada followed suit. Late in 2002 it was announced that the Medicines Control Agency (MeA) in the United Kingdom would also be banning kava; in February 2003 Swissmedic (formerly IKS) in Switzerland followed. At the time of writing, the Australian government is currently considering whether availability of therapeutic goods containing kava should be restricted. Since the action of the German authorities, government health administrations throughout the world have examined their databases for evidence of hepatotoxicity from kava use. Not surprisingly, more cases have come to light, but many of them are tenuous or inadequately reported. This chapter will review all known reported cases as of February 2003, with a view to arriving at an assessment as to whether the actions by the various health authorities have been justified. Much depends on the risk to benefit perspective. How much risk is acceptable for a herbal product? How good does the evidence need to be to arrive at a favourable risk-benefit assessment? The question must also be asked whether the interests of the consumer have been served by the complete banning of a herb that offered a viable alternative to conventional anxiolytic drugs, which are well known to have many risks associated with their use.en
dc.languageenen
dc.publisherElsevieren
dc.relation.ispartofThe Essential Guide to Herbal Safetyen
dc.relation.isversionof1en
dc.titleKava: A Risk-Benefit Assessmenten
dc.typeBook Chapteren
dc.subject.keywordsComplementary and Alternative Medicineen
local.contributor.firstnameMathiasen
local.contributor.firstnameMichelleen
local.contributor.firstnameKerryen
local.contributor.firstnameJaniceen
local.subject.for2008110499 Complementary and Alternative Medicine not elsewhere classifieden
local.subject.seo2008920412 Preventive Medicineen
local.identifier.epublicationsvtls086314892en
local.profile.schoolSchool of Healthen
local.profile.emailkbone2@une.edu.auen
local.output.categoryB1en
local.record.placeauen
local.record.institutionUniversity of New Englanden
local.identifier.epublicationsrecordpes:2763en
local.publisher.placeMissouri, USAen
local.identifier.totalchapters12en
local.format.startpage155en
local.format.endpage221en
local.title.subtitleA Risk-Benefit Assessmenten
local.contributor.lastnameSchmidten
local.contributor.lastnameMorganen
local.contributor.lastnameBoneen
local.contributor.lastnameMcMillanen
dc.identifier.staffune-id:kbone2en
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.profile.roleauthoren
local.identifier.unepublicationidune:2796en
dc.identifier.academiclevelAcademicen
local.title.maintitleKavaen
local.output.categorydescriptionB1 Chapter in a Scholarly Booken
local.relation.urlhttp://books.google.com.au/books?id=85M0N8UioCcCen
local.relation.urlhttp://nla.gov.au/anbd.bib-an26823751en
local.relation.urlhttp://www.elsevier.com/wps/find/bookdescription.cws_home/703510/descriptionen
local.description.statisticsepubsVisitors: 269<br />Views: 269<br />Downloads: 0en
local.search.authorSchmidt, Mathiasen
local.search.authorMorgan, Michelleen
local.search.authorBone, Kerryen
local.search.authorMcMillan, Janiceen
Appears in Collections:Book Chapter
Files in This Item:
3 files
File Description SizeFormat 
Show simple item record

Page view(s)

46
checked on Mar 3, 2019
Google Media

Google ScholarTM

Check


Items in Research UNE are protected by copyright, with all rights reserved, unless otherwise indicated.